BOSTON, April 2, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (DNA), which is building the leading platform for cell programming and biosecurity, announced the acquisition of Modulus Therapeutics' cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback